2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
about
Methotrexate for giant cell arteritisInterventions for renal vasculitis in adultsInterventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)Anti-cytokine therapies for primary systemic necrotizing vasculitisThe Prevalence and Management of Pauci-Immune Glomerulonephritis and Vasculitis in Western CountriesThe Prevalence and Management of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in ChinaNeutrophil Extracellular Traps in ANCA-Associated VasculitisTherapeutic advances in the treatment of vasculitisRecent advances in anti-neutrophil cytoplasmic antibody-associated vasculitisUrological Manifestations of Henoch-Schonlein Purpura: A ReviewDiagnostic approach and current treatment options in childhood vasculitisBehcet's Disease: Is There Geographical Variation? A Review Far from the Silk RoadClinical Features of Neuropsychiatric Syndromes in Systemic Lupus Erythematosus and Other Connective Tissue DiseasesSpotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectivesCerebral small vessel disease: Capillary pathways to stroke and cognitive declineEosinophilic Granulomatosis With Polyangiitis With Thrombotic Microangiopathy: Is Simultaneous Systemic Lupus Erythematosus Associated With Clinical Manifestations?: A Case Report and Review of the LiteratureCanVasc recommendations for the management of antineutrophil cytoplasm antibody (ANCA)-associated vasculitides - Executive summaryOutcome assessment in Takayasu arteritisInterstitial Lung Disease with ANCA-associated VasculitisNew developments in the genetics, pathogenesis, and therapy of IgA nephropathyAn update of neurological manifestations of vasculitides and connective tissue diseases: a literature reviewPathophysiological Relationship between Infections and Systemic VasculitisCharacterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvementsManagement of large-vessel vasculitis with FDG-PET: a systematic literature review and meta-analysisThe role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysisNovel clinical and diagnostic aspects of antineutrophil cytoplasmic antibodiesPulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literatureCurrent and future prospects in the management of granulomatosis with polyangiitis (Wegener's granulomatosis)The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitisInflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention.Monogenic polyarteritis: the lesson of ADA2 deficiencyBehçet's disease in children, an overviewUpdates in ANCA-associated vasculitisNon-infectious Inflammatory Lesions of the Sinonasal TractPolyarteritis nodosaRecent advances in Takayasu's arteritisPancreatic mass as an initial manifestation of polyarteritis nodosa: a case report and review of the literaturePTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysisFarm Exposure as a Differential Risk Factor in ANCA-Associated VasculitisThe immunopathology of ANCA-associated vasculitis
P2860
Q24185826-A3FF9A5B-F602-4A48-BDCE-3FF0A828813FQ24187038-438497DE-2C4B-465D-A9CB-D523FC7C527EQ24187962-E8B6CF8F-5770-486E-9DEB-BCA75AFB3217Q24241555-90FFA116-89ED-41F1-9E52-5784459C399EQ26740451-7A7EC6E3-0E7E-4174-B4B9-A367B55EFAF6Q26740453-A190D983-82F5-4006-A3C7-E5946CA06640Q26742162-41E12B2A-A18C-40BB-9008-6F51F7636249Q26750499-8A9E7625-E69D-448E-8F41-283DC870BC08Q26751357-A5B5099F-ECFC-46EB-AE58-47CB3159BC36Q26765012-C3C7CF40-BC69-4F8C-AEB3-BAC0D207115FQ26765359-0969F218-4770-4994-946D-736D120FD07BQ26770008-3D9E5D74-B5B6-4553-8497-D155D4C4F3BEQ26773164-A0367A83-985B-4C8D-A9E6-E31561FA73F5Q26776308-ED17F686-68F7-4686-998C-4152B11D476BQ26776375-310D6543-ACC5-44CC-BE1C-B1CAC1BC45E5Q26777537-EB8773D4-30EB-4F58-9CED-173267B2A9ACQ26777918-D9D928BB-F245-43C7-92AB-EDE3A63D7BE3Q26782601-6D6EB82D-8800-4B11-9C9B-1DD705292214Q26786104-C76DADD1-390F-46F2-9AF9-C8F17616B2D7Q26786248-0A5E7935-83D9-43F9-B1B2-AF02943D1387Q26796566-C101F765-8946-4560-B64F-55061234C63EQ26799915-55FFF39D-56BB-4052-8D9C-0D0AB82348ADQ26800693-606B6FBD-6E00-4B53-914A-458FA4B5066CQ26852724-621C02FE-CD9A-4351-AD82-58E89F5A20CAQ26853258-3E122FCA-8905-4DEB-BED7-720A6ACE712FQ27000411-4BDBCA86-0F20-4788-91DC-2FDEF1012BF4Q27008053-42925CD4-C7FB-47FD-AAE8-A274214F89B8Q27025692-2B9D7FF6-FC3C-4C7F-89D3-1E7472F18EE3Q27027790-C934B533-E214-43A6-A8D5-69F7C47E3225Q27322544-6EB79F18-EC83-46C6-A6EF-64E1708E9132Q28067372-44BAAAE9-60FE-4C02-ACD4-FD7A9BA209D7Q28069448-3D5E37A9-9670-4575-AA3B-62DED7C1C677Q28069897-09AB6EC0-DB8B-4EF7-822F-63543F6CCB8DQ28078321-CA0111FA-F3C2-45E0-9B0D-2B65C44D5096Q28080947-97A4863B-08C2-4927-BA15-51734ABF0B88Q28083670-456A84AB-33EF-4F97-82D7-812585AB2928Q28088713-214FFE92-6710-40E7-95E9-AE99CBECDC9EQ28387197-345803C7-D892-43D4-AEBC-BFBDF7E4B4CAQ28387801-D828C39A-AD56-4FDF-97E5-53D3A2E95863Q28391531-CC0738F3-6765-49E4-9FF4-6DEA9D90175C
P2860
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@ast
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@en
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@nl
type
label
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@ast
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@en
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@nl
prefLabel
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@ast
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@en
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@nl
P2093
P50
P3181
P356
P1476
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
@en
P2093
C A Langford
C G M Kallenberg
E L Matteson
F Ferrario
G S Hoffman
J C Jennette
P3181
P356
10.1002/ART.37715
P407
P577
2013-01-01T00:00:00Z